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THE GENETIC INFORMATION NONDISCRIMINATION ACT
OF 2008: HISTORY, SUCCESSES, AND FUTURE
CONSIDERATIONS
CHRISTINE FORMAS NORRIS*
The mapping of the human genetic code is one of the greatest
scientific achievements of the Twentieth Century.' To date, Congress
has committed $3.5 billion in the Human Genome Project with the
hope that genetic research will lead to great medical advances. 2 Many
considered genetic discrimination to be a major threat to these ad-
vances. 3 Genetic information can be used to deny individuals afford-
able health insurance or employment benefits.4 Genetic discrimination
can also manifest itself indirectly through genetic research and testing
that reinforces racial, ethnic, or gender stereotypes.5 Fear of genetic
discrimination may prevent individuals from seeking genetic testing or
from enrolling in genetic research.6 In a hearing before the Senate
Committee on Health, Education, Labor and Pensions, the President of
The National Partnership for Women and Families aptly stated:
No individual should have to choose between the bene-
fits of genetic testing and keeping a job or health insur-
ance. In some cases, fear of genetic discrimination can
be as destructive as traditional discrimination. Unless
Congress acts quickly and decisively, people's fears
may prevent them from getting the health care they
need. The more individuals fear discrimination, the less
willing they will be to participate in clinical trials and
studies that may require genetic testing - the very kind
* J.D., 2008. University of Maryland School of Law.
1. NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES, FACES OF GENETIC
DISCRIMINATION (2004), available at http://www.nationalpartnership.org/portals/p3/library/
GeneticDiscrimination/FacesofGeneticDiscrimination.pdf [hereinafter FACES].
2. Michael Hill, All in the DNA, BALT. SUN, Feb. 4, 2007, § 6, at 16 (interview with
Karen Rothenberg).
3. Id.
4. See discussion infra Part llI.A.
5. See discussion infra Part II1.D.
6. See discussion infra Part III.B and Part III.C.
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of research that could help us all live longer, healthier
lives.7
Congress found that federal health insurance, employment and
other anti-discrimination laws do not sufficiently protect individuals
from genetic discrimination. 8 While many states have passed genetic
nondiscrimination laws, their protections and approaches vary exten-
sively. 9 In response, Congress recently passed the Genetic Information
Nondiscrimination Act, which would prohibit a broad range of dis-
criminatory actions on the part of group health plans, health insurers
and employers. 10
While passage of the Genetic Information Nondiscrimination
Act of 2008 is a major accomplishment for policymakers, the medical
profession, researchers, and American citizens alike, several unre-
solved issues still remain.'' Most importantly, no serious steps have
been taken to regulate genetics research that can reinforce racial, eth-
nic and other group stereotypes. 12 In the future, policymakers should
consider whether regulatory standards or other forms of intervention in
group-identity based genetics research are necessary. 13
I. INTRODUCTION
It is best to start with a basic introduction to genetics and the
Human Genome Project. Each of us inherits a set of genes from our
parents.14 These genes are like blueprints for our body. From birth,
they predispose us to certain physical and even psychological charac-
teristics. 15 These characteristics may be as simple and stable as the
7. Protecting Against Genetic Discrimination: The Limits of Existing Laws: Hearing
on H.R. 1227 Before the S. Comm. on Health, Educ., Labor and Pensions, 107th Cong. (2002)
(testimony of Debra L. Ness), quoted in FACES, supra note 1, at 1.
8. Genetic Information Nondiscrimination Act, H.R. 493, 110th Cong. § 2 (2008).
9. See discussion infra Part IV.F.
10. Genetic Information Nondiscrimination Act, H.R. 493, 11 0th Cong. (2008) (en-
acted). The President signed the bill into law on May 21, 2008. See President Bush Signs H.R.
493, the Genetic Information Nondiscrimination Act of 2008 (May 21, 2008), available at
http://www.whitehouse.gov/news/releases/2008/05/20080521-7.html. A broad range of par-
ties, including business, professional, and community sponsors endorsed this bill. Janet
Brewer, "Diseases of Place ": Legal and Ethical Implications of Surname and Ethnicity as
Predictors of Disease Risk, 9 QUINNIPIAC HEALTH L.J. 155, 173 (2006).
11. See discussion infra Part V.C.
12. Id.
13. Id.
14. SRB ET AL., General Genetics (Freeman & Company, 1965).
15. Id.
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color of one's eyes. At the same time, they may be complex and less
predictable, creating predispositions to diseases like heart disease and
cancer. 16
The Human Genome Project is an international research pro-
gram coordinated by the National Institutes of Health. This organiza-
tion mapped the entire human genetic code in hopes of locating an es-
timated 50,000-100,000 genes and to understand how they affect our
bodies.' 7 The potential for medical advances arising from our knowl-
edge of the human genome is dramatic. Medical advances could range
from new methods of medical diagnosis and treatment to a new prac-
tice of personalized medicine and individualized drugs, genetically en-
gineered organs for transplants, and preventative care based on indi-
vidual's genes. However, the scope and significance of genomic
innovation as well as the ability of genetics to directly touch every-
one's lives raises serious moral and ethical concerns.19
The National Human Genome Research Institute has identified
genetic discrimination as one of the ethical dilemmas and greatest ob-
stacles to realizing the benefits of the Human Genome Project. 20 Ge-
netic discrimination is generally defined as prejudice against persons
who have a genetic predisposition towards an inherited disease. 2I Al-
16. H. Eiberg & J. Mohr, Major genes of eye color and hair color linked to LU and SE,
31 CLINICAL GENETICS 186, 186 (1987); H. Eiberg & J. Mohr, Assignment of genes coding for
brown eye colour (BEY2) and brown hair colour (HCL3) on chromosome J5q, 4 EUR. J HUM.
GENETICS 237, 237 (1996); R. A. Sturm & T. N. Frudakis, Eye colour: portals into pigmenta-
tion genes and ancestry, 20 TRENDS GENETICS 327, 327 (2004); see Presidential Radio Ad-
dress to the Nation, (June 23, 2001), available at www.whitehouse.gov/news/releases/
2001/06/20010623.html, quoted in NATIONAL PARTNERSHIP FOR WOMEN AND FAMILIES, FACES
OF GENETIC DISCRIMINATION (July 2004), available at http://www.nationalpartnership.org/
portals/p3/library/GeneticDiscrimination/FacesofGeneticDiscrimination.pdf ("A genetic pre-
disposition to cancer or heart disease does not mean that the condition will develop.").
17. Nat'l Human Genome Research Inst., An Overview of the Human Genome Project,
available at http://www.genome.gov/12011238 (last visited Jan. 2007).
18. The Chattanoogan.com, Frist Applauds Senate Passage of Genetic Discrimination
Protections Bill, available at http://www.chattanoogan.com/articles/article_42097.asp (Oct 14,
2003); see also STATEMENT OF ADMINISTRATIVE POLICY, S.306, GENETIC INFORMATION
NONDISCRIMINATION ACT OF 2005, (Feb. 16, 2005).
19. See Nat'l Human Genome Research Inst., Policy and Program Analysis Branch,
available at http://www.genome.gov/10001087 (last visited Jan. 2007); see generally Nat'l
Human Genome Research Inst., Policy and Ethics, available at http:/lwww.genome.gov/
PolicyEthics (last visited Jan. 2007) (see for a list of genomics ethics and policy issues).
20. Nat'l Human Genome Research Inst., Genetic Discrimination, available at
http://www.genome.gov/10002077 (last updated Feb. 2007).
21. U.S. Dept. of Energy Office of Sci., Human Genome Program, Genome Glossary,
available at http://www.oml.gov/sci/techresources/HumanGenome/glossary/glossary-g.
shtml (last modified Oct. 29, 2003) (definition also includes discrimination against those who
have actually developed a disorder).
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though genetic discrimination is a relatively new concept, it is analo-
gous to other forms of discrimination. First, our genetic profiles are
immutable characteristics, because much like race and gender, our
genes are inherited and unalterable. 22 Second, genetic discrimination is
based on status or category rather than actual conditions.23 Having a
genetic predisposition to a disorder does not mean the disorder is cer-
tain to develop.24 For instance, complex genetic disorders such as
heart disease and cancer are influenced by a myriad of genes and envi-
ronmental factors, each having an ability to predispose or prevent a
person from developing the disease. 2 5 In such cases, genetic predispo-
sition may be little more than medical speculation. 26 Therefore, an in-
dividual testing positive for a genetic susceptibility, such as to cancer,
could be discriminated against for a condition that will never manifest.
However, unlike other forms of discrimination, genetic discrimination
has the potential to affect every human being because every human
carries approximately five to seven fatal recessive genes 27 and up to
thirty predispositions to various disorders. 28 For this reason, a wide va-
riety of groups have expressed concern over genetic discrimination.
29
II. THE AFFECTED CLASS: A PATIENT'S PERSPECTIVE
Imagine that your physician just diagnosed you with Polycystic
Kidney Disease (PKD), the world's most common life threatening ge-
netic disease. 30 Painful kidney cysts, kidney stones, urinary tract infec-
tions, and high blood pressure, as well as problems in other organs
22. Cf Frontiero v. Richardson, 411 U.S. 677 (1973) ("Since sex, like race and national
origin, is an immutable characteristic determined solely by the accident of birth, the imposi-
tion of special disabilities upon the members of a particular sex because of their sex would
seem to violate the basic concept of our system that legal burdens should bear some relation-
ship to individual responsibility.").
23. Genetic Discrimination and Polycystic Kidney Disease: News Conference on H.R.
1227 Before House, 109th Cong. (2006) [hereinafter PKD News Conference].
24. Presidential Radio Address to the Nation, supra note 16.
25. Id.
26. Id.
27. Alexander M. Capron, Which Ills to Bear?: Reevaluating the "Threat" of Modern
Genetics, 39 EMORY L. J. 665, 690 (1990).
28. Louis M. Slaugher, Genetic Information Must Remain Private to Prevent Discrimi-
nation, Spur Research, 2 GENETIC TESTING 17, 19 (1998).
29. See generally FACES, supra note 1.
30. See Polycystic Kidney Disease, NAT'L KIDNEY AND UROLOGIC DISEASES
CLEARINGHOUSE (Nat'l Kidney and Urologic Diseases Clearinghouse, Bethesda, MD), 1996,
at 1, available at http://kidney.niddk.nih.gov/kudiseases/pubs/polycystic/ (describes three
types of polycystic kidney disease and its genetic origins, symptoms, diagnosis, and treatment,
as well as ongoing research) [hereinafter PKD].
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such as brain aneurysms, abnormal heart valves, and cysts in other or-
gans characterize PKD.31 To make matters worse, you now know that
you have a fifty/fifty chance of developing kidney failure.
32
Your physician informs you that a genetic test is available for
PKD.33 You urge your much younger sister to get tested because the
condition may otherwise be undiagnosable for decades and, as a young
woman, she may be able to forestall the disease through diet and blood
pressure control.34 Sadly, she tested positive for mutations in the
PKD1 and PKD2 genes that cause PKD.35 After receiving her results,
she is repeatedly turned down for life insurance and health care insur-
ance 36 even though her condition may not develop for another twenty
years and the severity of the disease may be mild enough to be con-
trolled by over-the-counter pain and blood pressure medications.
37
Perplexingly, insurers singled her out as a high risk, when PKD is not
even the leading cause of kidney failure in this country. 38 Your sister
fears the impact that her test results may have on her career if her em-
ployer finds out.
39
After your sister's ordeal, you choose not to pursue genetic
testing for your child because you fear for your son's job opportunities
and health or life insurance coverage in the future. But your own ge-
netic test results are a part of your son's family history, so insurers
may already take into consideration the fact that your son has a fifty
percent chance of inheriting the disease from you.4' You avoid testing
although he may be able to safely donate a kidney to you one day
should he test negative for PKD. 42 When your physician asks your
family to participate in PKD genetic research, you decline because you
are afraid that your genetic information may be disclosed.43
31. Id.
32. See id.
33. See id.
34. See id.
35. See PKD, supra note 30.
36. See PKD News Conference, supra note 23.
37. See PKD, supra note 30.
38. See id. PKD is only the fourth leading cause of kidney failure. Id.; see also Diabetes
and Blood Pressure, Two Leading Causes of Kidney Disease, NAT'L KIDNEY DISEASE EDUC.
PROGRAM (Nat'l Kidney Disease Educ. Program), May 2006, at 1, available at
http://nkdep.nih.gov/resources/NKDEP GenPopBrochure_508.pdf.
39. See PKD News Conference, supra note 23.
40. See id.
41. See PKD, supra note 30.
42. Id.
43. Id; see also PKD News Conference, supra note 23.
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One can put the concept of genetic discrimination in context by
reflecting back on the personal struggles of members of the Polycystic
44Kidney Disease Association. Like PKD, genetic diseases can range
from mild to serious. While a correct diagnosis can aid in treatment
and perhaps even preventative treatments for the sufferer and their
family, it can also subject them to genetic discrimination. Congress
passed the Genetic Information Nondiscrimination Act to precisely
address such concerns.
45
III. THE ISSUES: How DOES GENETIC DISCRIMINATION MANIFEST
ITSELF?
A. Employment and Insurance Discrimination
Although genetic discrimination can be manifested in a number
of different ways, genetic discrimination in health insurance and em-
ployment is most disconcerting and has been most frequently re-
ported.46 Issuers of health insurance have denied healthy individuals
(much like our PKD sister) health insurance, increased the cost of cov-
erage, or limited insurance benefits because of that individual's genetic
information.47 Similarly, employers have denied healthy individuals
employment, fired current employees, or denied workers compensa-
tion benefits on the basis of genetic information. According to the
American Management Association, employers are accessing genetic
information in a number of ways:
49
*[O]ne percent was conducting genetic tests for Sickle Cell
Anemia, 0.4 percent was testing for Huntington's dis-
ease
44. See PKD News Conference, supra note 23.
45. Genetic Information Nondiscrimination Act, H.R. 493, 110th Cong. § 101-102
(2008).
46. FACES, supra note 1, at 3.
47. Id.
48. Id; see also Nat'l Human Genome Research Inst., Cases of Genetic Discrimination,
available at http://www.genome.gov/12513976 (last visited Dec. 2006) ("Despite claims of
hundreds of genetic-discrimination incidents, an article from the January 2003 issue of the Eu-
ropean Journal of Human Genetics reports a real need for a comprehensive investigation of
these claims. The article warns that many studies rely on unverified, subjective accounts from
individuals who believe employers or insurance companies have unfairly subjected them to
genetic discrimination.").
49. Privacy Concerns Raised by the Collection and Use of Genetic Information by Em-
ployers and Insurers: Hearing before the Subcommittee on the Constitution of the H. R. Comm.
on the Judiciary, 107th Cong. (Sept. 12, 2002), cited in FACES, supra note 1, at 3.
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*Fourteen percent were conducting workplace susceptibil-
ity testing which surveyors acknowledged might in-
clude genetic testing
*Twenty percent were requesting family medical histo-
ries.
In addition, twenty-two percent of individuals surveyed that are
at risk, pre-symptomatic, or asymptomatic for a number of genetic dis-
eases, identified a number of institutions that discriminated against
them, including health and life insurers, employers, clinical profes-
sionals, blood banks, and public institutions.
51
B. Avoidance of Genetic Testing
Although there have been a number of well-documented cases
of discrimination, no case directly claiming genetic discrimination has
been brought before a United States federal or state court. 52 Experts
speculate that many individuals and their family members are forgoing
genetic testing in order to avoid discrimination in the first place.' Un-
like race, ethnicity, religion, or gender, genetic predispositions are not
readily apparent without laboratory genetic testing, physical medical
examinations, or the disclosure of family medical histories.54 There-
fore, a fear of genetic discrimination may keep individuals, like the
above hypothetical PKD family, from undergoing tests that could pro-
vide them with valuable information concerning their health, including
predispositions to diseases they may be able to take preventative action
against, possible adverse drug reactions, or hereditary diseases.55
50. Id.
51. M. Adya & B. Bornstein, Genetic Discrimination and Discrimination in Employ-
ment: A Psycho-legal Perspective, 32 Wm. Mitchell L. Rev. 265, at 275-276 (2005) (citing
Lisa Geller et al., Individual, Family and Societal Dimensions of Genetic Discrimination: A
Case Study Analysis in The Double-Edged Helix, Social Implications of Genetics in a Diverse
Society 247 (2002)).
52. FACES, supra note 1, at 3.
53. PKD, supra note 30 (Patients with polycystic kidney disease would not genetically
test their children to see if they had a predisposition to the disease because they feared for their
child's ability to obtain health insurance or employment when they got older.).
54. Id.
55. OFFICE OF MANAGEMENT AND BUDGET, STATEMENT OF ADMINISTRATIVE POLICY, S.
306 - GENETIC INFORMATION NONDISCRIMINATION ACT OF 2005 (Feb. 16, 2005), available at
http://www.whitehouse.gov/omb/legislative/sap/l09-1/s3O6sap-s.pdf; OFFICE OF MANAGE-
MENT AND BUDGET, STATEMENT OF ADMINISTRATIVE POLICY, S. 1053 - GENETIC INFORMATION
NONDISCRIMINATION ACT OF 2003 (Oct. 14, 2003), available at http://www.whitehouse.gov/
omb/legislative/sap/108- I/s 1053sap-s.pdf.
2007] GENETIC INFORMATION NONDISCRIMINATION ACT 199
The fear of genetic discrimination has adversely impacted ge-
netic testing for breast cancer susceptibility in exactly this way.56
Women with BRCA1 or BRCA25 7 genetic mutations have an ex-
tremely high lifetime risk of breast cancer (50-85%) and increased
risks of ovarian cancer (10-40%). 58 Some women who test positive ob-
tain preventative mastectomies, oophorectomies, and hysterectomies to
reduce their risk of breast and ovarian cancer. 59 While BRAC 1/2 test-
ing is widely available and women are highly interested in such
screening, only about half of all eligible women choose to be tested.60
Research shows that:
Individuals considering BRAC1/2 testing consistently
identify health insurance discrimination among their
major concerns about testing ... In one testing pro-
gram, 34% of individuals reported that the possibility of
losing health insurance was a major risk of having
BRCA1 testing ... In order to avoid discrimination,
many of the respondents ... obtained insurance prior to
any genetic testing, received testing that could not be
linked back to them personally, only partially disclosed
relevant information, and personally paid for testing
that would ordinarily be paid for by insurers.
61
C. Reluctance to Participate in Genetics Research
Genetic discrimination also has the effect of reducing the num-
ber of willing participants in clinical research because individuals are
afraid their genetic information could be disclosed and used for ille-
56. See generally Katherine A. Schneider, Adverse Impact of Predisposition Testing on
Major Life Activities: Lessons from BRAC1/2 Testing, 3 J. HEALTH CARE L. & POL'Y 365
(2000) (discussion on impact of the perception of genetic discrimination on BRACI/2 testing).
57. NATIONAL CANCER INSTITUTE, available at http://www.cancer.gov/cancertopics/
factsheet/Risk/BRCA (last visited Feb 6, 2002) ("Inherited alterations in the genes called
BRCA I and BRCA2 (short for breast cancer I and breast cancer 2) are involved in many cases
of hereditary breast and ovarian cancer. Researchers are searching for other genes that may
also increase a woman's cancer risk.").
58. Katherine A. Schneider, Adverse Impact of Predisposition Testing on Major Life
Activities: Lessons from BRAC1/2 Testing, 3 J. HEALTH CARE L. & POL'Y 365, 367 (2000)
(discussion on impact of the perception of genetic discrimination on BRACI/2 testing).
59. Id.
60. Id. at 378 (for a multitude of reasons, including genetic discrimination, perceptions
of testing and psychological impact); see also Adya, supra note 51, at 278-79.
61. See also Schneider, supra note 56, at 377.
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62gitimate purposes. Ironically, this is precisely the type of research
that is necessary to find new treatments and to improve our under-
standing of genetic diseases. 63 This may also affect the development of
new genetic tests. 64 In the late 1990s, investors were warned that ge-
netic discrimination may affect investment in biotechnology. 65 Conse-
quently, the biotechnology industry is generally supportive of genetic
nondiscrimination legislation because of their increasing reliance upon
genetic testing, pharmacogenomics, population-based genetic research,
and innovative genetic technologies.
6
D. Reinforcement of Ethnic/Racial/Group Stereotypes
Much like other physical characteristics, genes define one's
race, ethnic background, sex, and possibly sexual orientation. 67 There-
fore, genetic research associated with such groups has the potential to
reinforce group stereotypes. 68 Historically, ethnic and racial discrimi-
nation have even been "justified" by genetic research.6 9 For example,
Nazi atrocities, sterilization policies, and Eastern European immigra-
tion restrictions in the 1920s were justified by genetic findings during
the eugenics movement.70 Today, Ashkenazi Jewish, African-
62. OFFICE OF MANAGEMENT AND BUDGET, STATEMENT OF ADMINISTRATIVE POLICY, S.
306 - GENETIC INFORMATION NONDISCRIMINATION ACT OF 2005 (Feb. 16, 2005), available at
http://www.whitehouse.gov/omb/legislative/sap/109-1/s306sap-s.pdf.
63. Id.
64. Janet Brewer, "Diseases of Place ": Legal and Ethical Implications of Surname and
Ethnicity as Predictors of Disease Risk, 9 QUINNIPIAC HEALTH L. J. 155, 170-171 (2006).
65. Id. at 170-71.
66. Id. at 171 ("Laboratory Corporation of America (LabCorp), one of the largest pro-
viders of genetic testing services in the United States, has recognized the potential for genetic
discrimination and has endorsed appropriate policies to protect individuals. To that end, Lab-
Corp was a cosignatory of a letter supporting genetic nondiscrimination legislation in the
United States House of Representatives posted by the Genetic Alliance in 2005.").
67. THE COUNCIL FOR RESPONSIBLE GENETICS, Do GENES DETERMINE WHETHER WE ARE
LESBIAN, GAY, BISEXUAL, OR STRAIGHT?, available at http://www.gene-watch.org/programs/
privacy/gene-sexuality.html (position paper) (last visited Feb. 15, 2007).
68. The Potential for Discrimination in Health Insurance Based on Predictive Genetic
Tests: Hearing before the Subcomm. on Commerce, Trade and Consumer Prot. of the H.
Comm. on Energy and Commerce, 106th Cong. (July 11, 2001) (testimony of KAREN H.
ROTHENBERG), available at http://energycommerce.house.gov/l07/Hearings/07112001
hearings322/Rothenberg52 I.htm, cited in FACES, supra note 1, at 14.
69. Id.
70. Id., ELOF CARLSON, SCIENTIFIC ORIGINS OF EUGENICS, available at
http://www.eugenicsarchive.org/html/eugenics/essay2text.html (last visited Aug. 30, 2007)
("The eugenics movement arose in the 20th century as two wings of a common philosophy of
human worth. Francis Galton, who coined the term eugenics in 1883, perceived it as a moral
philosophy to improve humanity by encouraging the ablest and healthiest people to have more
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American, and Native-American communities have all raised concerns
over research implying genetic tendencies towards violence, alcohol-
ism, or genetic abnormalities suggesting racial or ethnic inferiority. 7'
In one prime example of genetic discrimination, states insti-
tuted mandatory sickle cell anemia screening programs for African-
Americans in the 1970s, even though other races and ethnicities were
at risk for the disease.72 A seemingly innocent screening program de-
signed to protect anemics was used for racially discriminatory ends. 73
Screening programs identified both individuals with sickle cell anemia
and healthy carriers of one sickle cell gene that could not develop the
disease. 74 Test results were not confidential. 75 Healthy carriers were
subsequently stigmatized and discriminated against in employment
and health insurance. 76 As a result, Congress passed the National
Sickle Cell Anemia Control Act in 1972, barring states from receiving
federal funds unless their sickle cell screening programs are volun-
tary.77 Similar discriminatory programs could be implemented today
with respect to other genetic conditions.
IV. THE FINDINGS/MOTIVATION: INADEQUATE LEGAL PROTECTIONS
Sufficient legal protections against genetic discrimination did
not exist at law prior to the Genetic Information Nondiscrimination
Act. 78 Although certain federal statutory schemes may apply to genetic
children. The Galtonian ideal of eugenics is usually termed positive eugenics. Negative eugen-
ics, on the other hand, advocated culling the least able from the breeding population to pre-
serve humanity's fitness. The eugenics movements in the United States, Germany, and Scan-
dinavia favored the negative approach.").
71. The Potential for Discrimination in Health Insurance Based on Predictive Genetic
Tests: Hearing before the Subcomm. on Commerce, Trade and Consumer Prot. of the H.
Comm. on Energy and Commerce, 106th Cong. (July 11, 2001) (testimony of KAREN H.
ROTHENBERG), available at http://energycommerce.house.gov/107/Hearings/07112001
hearings322/Rothenberg521.htm, cited in FACES, supra note 1, at 14.
72. FACES, supra note I, at 14 ("At that time, scientists had raised concerns that indi-
viduals with sickle cell anemia carried a heightened risk from some workplace toxins.") avail-
able at http://www.genome.gov/l10002401.
73. Id.
74. Id.
75. Id.
76. Id.
77. 42 USCS § 300(b)(1) (omitted in the general revision of Title XI of the 1944 Act by
Act April 22, 1976).
78. See generally Robert B. Lanman, An Analysis of the Adequacy of Current Law in
Protecting Against Genetic Discrimination in Health Insurance and Employment (May 2005),
available at http://www4.od.nih.gov/oba/SACGHS/reports/legal analysis May2005.pdf (In
2005, the Health and Human Services Secretary's Advisory Committee on Genetic, Health
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discrimination, the protections are limited and it is uncertain how
courts will interpret these laws in the context of genetic information.79
In addition, state genetic nondiscrimination laws vary widely in their
approach, application, and level of protection. 80 The federal govern-
ment assessed how the following laws could protect individuals from
genetic discrimination and found that each law was inadequate.
A. Constitutional Right to Privacy
In Norman-Bloodsaw v. Lawrence Berkeley Lab, the Ninth
Circuit Court of Appeals found a constitutional right to privacy of ge-
netic information. In this case, employees at a research facility under-
went genetic testing for sickle cell anemia without their knowledge.
81
The court held that the employee's right to privacy of their genetic in-
formation is protected under the Fourth Amendment searches and sei-
zures and under the Fifth and Fourteenth Amendment Due Process
Clauses. 82 The court held that the analysis of a bodily sample to obtain
physiological data involves a search and seizure of information over
which a person has a legitimate expectation of privacy. 83 The court
specifically stated that there are "few subject areas more personal and
more likely to implicate privacy interests than that of one's health or
genetic make-up."
84
However, the Ninth Circuit remanded the case to determine
whether the defendant company had any interest in obtaining the ge-
netic information. 85 While it is uncertain what level of constitutional
scrutiny this issue will encounter (rational basis, intermediate, or strict
scrutiny), the court's decision suggests that a state's interests may
and Society commissioned a paper to study the adequacy of current law in protecting against
genetic discrimination in health insurance and employment. The Department of Justice, De-
partment of Labor, Equal Opportunity Commission, Centers for Medicare & Medicaid Ser-
vices and Office for Civil Rights assisted in the development of this report. Findings from this
paper were used to support and develop the Genetic Information Nondiscrimination Act. The
paper contains much background material on anti-discrimination laws as they may apply to
genetic discrimination.).
79. See generally Lanman, supra note 78, at 20.
80. See, e.g., Genetic Information Nondiscrimination Act, H.R. 493, 1 10th Cong.
(2008).
81. Norman-Bloodsaw v. Lawrence Berkeley Lab., 135 F.3d 1260 (9th Cir. 1998) at
1265; Lanman, supra note 78, at 20.
82. Norman-Bloodsaw, 135 F.3d at 1268-1270; Lanman, supra note 78, at 21.
83. Norman-Bloodsaw, 135 F.3d at 1270 n. 13, cited in Lanman, supra note 78, at 2 1.
84. Norman-Bloodsaw, 135 F.3d at 1268-1270; Lanman, supra note 78, at 20.
85. Id.
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outweigh a claim of privacy of genetic information.86 In addition, such
constitutional protections only apply to government action, and there-
fore private employers and insurance companies are immune from suit
under constitutional privacy claims.
87
B. The Americans with Disabilities Act and The Rehabilitation Act
Federal laws that prohibit disability discrimination, such as the
American's With Disabilities Act (ADA)88 and the Rehabilitation Act
(RA), 89 provide partial protections to genetic discrimination. These
statutes prohibit discrimination based on the existence or perception of
a disability. The ADA is applicable to private employers having fifteen
or more workers, labor organizations, employment agencies, and state
and municipal government agencies, 90 while the RA applies to federal
employers only.
91
In 2001, the U.S. Equal Employment Opportunity Commission
(EEOC) settled the first lawsuit directly alleging genetic discrimina-
tion in employment under the ADA. 92 In Burlington Northern Santa
Fe (BNSF) v. EEOC, BNSF Railroad tested its employees without
their knowledge for a genetic condition that causes carpal tunnel syn-
drome. 93 BNSF additionally threatened one employee with termination
when they refused to comply. 94 According to the EEOC, the genetic
tests were unlawful under the ADA because they were not job-related,
86. Norman-Bloodsaw, 135 F.3d at 1275, cited in Lanman, supra note 78, at 21. In Wha-
len v. Roe, a case cited extensively by Norman-Bloodsaw the Supreme Court found that a con-
stitutional right to privacy of medical information exists, but a state's interest in access to such
information outweighs that right. Whalen v. Roe, 429 U.S. 589 (1977), cited in Lanman, supra
note 78, at 21. See Norman-Bloodsaw v. Lawrence Berkeley Lab., 135 F.3d 1260, 1265 (9th
Cir. 1998); Lanman, supra note 78, at 20.
87. See Norman-Bloodsaw, 135 F.3d at 1269, cited in Lanman, supra note 78, at 21;
U.S. CONST. AMEND IV.
88. 42 U.S.C. § 12102.
89. 29 U.S.C. § 79.
90. 42 U.S.C. § 12102.
91. 29 U.S.C. § 791.
92. EEOC v. Burlington Northern Santa Fe Railroad, Civ. No. 01-4013 MWB
(N.D.L.A. April 23, 2001) (Agreed Order); see also JEAN P. KAMP, EEOC PETITIONS COURT
TO BAN GENETIC TESTING OF RAILROAD WORKERS IN FIRST EEOC CASE CHALLENGING
GENETIC TESTING UNDER AMERICANS WITH DISABILITIES ACT (Feb. 9, 2001),
http://www.eeoc.gov/press/2-9-01-c.html; see also JEAN P. KAMP, EEOC AND BNSF SETTLE
GENETIC TESTING CASE UNDER AMERICANS WITH DISABILITIES ACT (MAY 8, 2002),
http://www.eeoc.gov/press/5-8-02.html.
93. EEOC, Civ. No. 01-4013 MWB; Lanman,supra note 78, at 17.
94. Id.
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and conditioning employment on genetic test results constituted dis-
ability discrimination.
95
While the ADA and RA may be applied in genetic discrimina-
tion cases, the scope of their protections is limited. First, the statutes
define a disability as a substantially limiting impairment. 96 To be sub-
stantially limiting, a disability would have to be expressed in the past
or present.97 Therefore, neither statute would protect currently healthy
individuals with genes that increase their susceptibility to certain dis-
orders.98 Second, these statutes only limit how an employer uses ge-
netic information. They do not prevent employers from generally in-
quiring about genetic information.99 An employer could potentially
require genetic tests as a condition of employment and not extend of-
fers to those with genetic traits that the employer deems undesir-
able. oo
The affect of the ADA on genetic discrimination in health in-
surance is more tenuous. While the ADA regulates insurance offices as
places of public accommodation, the Supreme Court has not spoken as
to whether the ADA regulates the content of insurance policies, such
as cost or coverage limitations.' 01 Therefore, the ADA may not pre-
vent issuers of health insurance from using genetic information to alter
enrollment policies or the terms and conditions of a health insurance
policy.
C. Health Insurance Portability and Accountability Act of 1996
The Health Insurance Portability and Accountability Act of
1996 (HIPAA) is the only statute that directly prohibits certain uses of
genetic information. 102 It directly prohibits group health plans from us-
ing genetic information to increase the cost of health insurance, or lim-
95. Id.
96. Lanman, supra note 78, at 13; see also Nat'l Human Genome Research Inst., Exist-
ing Federal Anti-Discrimination Laws and How They Apply to Genetics, available at
http://www.genome.gov/12513979 (last visited Jan. 5, 2007) [hereinafter Existing Fed. Anti-
Discrim. Laws].
97. 42 U.S.C. § 12102.
98. Lanman, supra note 78, at 13; see also Existing Fed. Anti-Discrim. Laws, supra note
96.
99. Lanman, supra note 78, at 13.
100. Lanman, supra note 78, at 12-13; see also Existing Fed. Anti-Discrim. Laws, supra
note 96.
101. 42 U.S.C. 12181(7)(F); Lanman, supra note 78, at 5.
102. 29 U.S.C. § 1181; 42 U.S.C. § 300; 26 U.S.C. § 9801.
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it or deny individuals coverage. J03 HIPAA also prohibits group health
plans and health insurers from treating genetic information as preexist-
ing conditions, unless an individual is diagnosed with a medical condi-
tion that is related to the genetic information.' 
04
Unfortunately, HIPAA protections against genetic discrimina-
tion in health insurance fail in several ways. First, while prohibiting
individual cost increases, HIPAA does not prevent insurance providers
from charging entire groups of individuals more or increasing an em-
ployer's overall premium based on genetic information. 105 Second,
while HIPAA prevents an issuer of insurance from denying a policy to
a small employer because of an enrollee's genetic information, this
prohibition does not apply to large employers.' 06 Third, HIPAA does
not apply to insurance policies for individuals, which includes 10-15%
of people with health insurance.' 0 7 Finally, HIPAA does not Prohibit
employers from denying insurance coverage to any individuals. 
08
D. Employee Retirement Income Security Act/Social Security Act
The ability of the Social Security Act (SSA) to protect against
genetic discrimination is especially tenuous. The Employee Retirement
Income Security Act sets national standards for Medicare supplemen-
tal health insurance policies (Medigap) offered by states and private
issuers of health insurance.' °9 Medigap issuers may not condition or
price Medigap policies based on "health status, claims experience, or
receipt of medical care or medical condition" of the applicant.' 10 In
addition, Medigap may not exclude benefits because of a pre-existing
condition.'" Besides the limited applicability of these policies to
Medigap, the statute does not describe and no court has determined
103. 29 U.S.C. § 1181, 42 U.S.C. § 300, 26 U.S.C. § 9801 (defining preexisting condi-
tion, permit preexisting condition exclusions under limited circumstances and allow for the
portability of health insurance plans); see also Existing Fed. Anti-Discrim. Laws, supra note
96; see also Lanman, supra note 78, at 2.
104. 29 U.S.C. § I181(b)(1)(B); 42 U.S.C. § 300(b)(1)(B); 26 U.S.C. § 9801(b)(1)(b);
see also Existing Fed. Anti-Discrim. Laws, supra note 96; see also Lanman, supra note 78, at
2.
105. Lanman, supra note 78, at 3.
106. 45 C.F.R. 146.150; see also Lanman, supra note 78, at 3.
107. Lanman, supra note 78, at 4.
108. Existing Fed. Anti-Discrim. Laws, supra note 96; see also Lanman, supra note 78, at
4.
109. See Lanman, supra note 78, at 5.
110. 42 U.S.C. § 1395ss(s)(2)(A); 42 U.S.C. § 1395ss(s)(3)(A); see also Lanman, supra
note 78, at 5.
111. 42 U.S.C. § 1395(s)(3)A)(iii); Lanman, supra note 78, at 5.
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how, if at all, these restrictions apply to genetic information." 2 There-
fore, even Medigap may not protect its own policyholders from ge-
netic discrimination.
E. Title VII of the Civil Rights Act of 1964
Title VII of the Civil Rights Act of 1964 prohibits discrimina-
tion on the basis of race, color, religion, sex, and national origin in
employment. 113 Title VII protects against genetic discrimination where
group identities 114 are used as a proxy to discriminate against indi-
viduals with genetic predispositions.'In Norman-Bloodsaw v. Law-
rence Berkeley Lab, the court found that testing African-American's
exclusively for sickle cell disease violated Title VII because the re-
search facility singled out African-Americans on the basis of race.
116
However, Title VII protections are limited because most genetic disor-
ders do not disproportionately affect a protected class such as African-
Americans. 117 Therefore, Title VII offers little protection from em-
ployment discrimination for many individuals.
F. State Statutory Protections
Thirty-four states have passed some form of legislation that
prohibits genetic discrimination by employers." 8 However, the form
and function of these laws vary extensively. 19 While many states bar
discrimination based on genetic testing, not all states bar discrimina-
tion based on other sources of genetic information such as family his-
tory. 120 Even fewer states restrict employer access to genetic informa-
tion in the first place.' 21 Only fourteen states prescribe specific
penalties for genetic discrimination by employers.'
112. Lanman,supra note 78, at 5.
113. 42 U.S.C. § 2000; Lanman,supra note 78, at 19.
114. Such as race, color, religion, sex, and national origin.
115. Lanman, supra note 78, at 19.
116. Norman-Bloodsaw, 135 F.3d (similarly holding that pregnancy testing discriminated
against women and pregnant women); Lanman, supra note 78, at 19.
117. See comment supra 34.
118. ALISSA JOHNSON, STATE GENETICS EMPLOYMENT LAWS, NATIONAL CONFERENCE OF
STATE LEGISLATURES, (November 2006), available at http://www.ncsl.org/programs/health/
genetics/ndiscrim.htm.
119. Id.
120. Id.
121. Id.
122. Id.
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Similarly, while a majority of states enacted laws that restrict
genetic discrimination by health insurers, their form, function and ap-
plicability vary extensively.1 23 Some anti-insurance discrimination sta-
tutes may govern individual insurance policies, and not group insur-
ance, or vice versa. 124 These statutes can never apply to employer-
sponsored health benefit plans because these plans are governed solely
by the federal government. 125 These statutes also vary in the types of
activities they restrict, such as conditioning insurance coverage and
cost on genetic information or requiring genetic testing.1 26 Few states
have statutes that restrict genetic discrimination in life, disability and
long-term care insurance.127 In addition, variations in individual state
laws give insufficient warning to insurers and employers operating
across state lines, creating high transaction costs associated with de-
termining the scope of individual state statutes.12
8
V. THE SOLUTIONS
A. What Kind of Response Was Necessary?
Some critics continue to argue that genetic discrimination is an
acceptable insurance and employment practice. 129 Their reasoning is
that genetic risk is no different from other risks that employers and in-
surers have a right to know about, and therefore, patients should fully
disclose their genetic information to employers and insurers. 130 It must
be stressed that the science of genomics is still evolving as is our un-
derstanding of genetic predisposition to certain disease. Therefore, ge-
netic markers are not always accurate predictors of disease.1 31 Once
again, genetic background is an unacceptable form of classification
because a person has a right not to be classified for insurance or em-
ployment purposes unless the classification corresponds to an accurate
123. ALISSA JOHNSON, GENETICS AND HEALTH INSURANCE STATE ANTI-DISCRIMINATION
LAWS, NATIONAL CONFERENCE OF STATE LEGISLATURES (June 2005), http://www.ncsi.org/
programs/health/genetics/ndishlth.htm.
124. Id.
125. Id.
126. Id.
127. Id.
128. See JOHNSON, supra note 118.
129. See Epstein supra note 139; see Kathleen Taradash, Preventing a Market for "Lem-
ons ": A Voluntary Disclosure Model as an Alternative to the Prohibition of Genetic Discrimi-
nation and the Distortion ofAllocative Efficiency, 34 CONN. L. REV. 1353, 1353 (2002).
130. Id.
131. Id.
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and predictable risk. 132 Given the seriousness of genetic discrimina-
tion 33 and the incomplete protections of federal and state laws, 134 the
federal government passed the Genetic Information Nondiscrimination
Act.
B. Genetic Information Nondiscrimination Act
The Genetic Information Nondiscrimination Act (GINA) is a
comprehensive bill that prohibits employment and insurance discrimi-
nation based on genetic information. 135 In general, the act bars group
health plans and health insurers from conditioning the health insurance
of healthy individuals based solely on genetic information.' 36 The leg-
islation would also bar employers from hiring, firing, placing, or mak-
ing promotional decisions based solely on an individual's genetic in-
formation. 137 The Act fills in many of the missing gaps in the
Employee Retirement Income Security Act of 1974 (ERISA), the Pub-
lic Health Service Act and Title XVIII of the Social Security Act relat-
ing to Medigap. 1
38
1. Prohibitions Against Health Insurance Discrimination
GINA amends several of the previously mentioned statutes
1 39
to protect against genetic discrimination in health insurance. Most im-
portantly, the statute amends ERISA, the Public Health Service Act,
the Internal Revenue Code, and portions of the Social Security Act re-
lating to Medigap. 140 First, it bars group health plans and issuers of
health insurance from restricting health insurance enrollment because
of the receipt or requests for genetic testing either by an individual or
their family member.' 1 Second, group health plans and issuers of
health insurance may not use genetic information to adjust premiums
132. Jill Gualding, Race, Sex, and Genetic Discrimination in Insurance: What's Fair?, 80
CORNELL L. REv. 1646, 1648 (1995) (noting that efficient discrimination is the idea that accu-
rate indicators of risk should used in businesses founded on risk assessment).
133. See discussion supra Part Ill.
134. See discussion supra Part IV.
135. H.R. 493, 110th Cong. (2008).
136. Id. § 101-105.
137. Id. § 201-205 (2008).
138. H.R. 493, 110th Cong. (2008).
139. See discussion supra Part IV.
140. Genetic Information Nondiscrimination Act, H.R. 493, 11 0th Cong. § 10 1-104
(2008).
141. Id.
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or health insurance pricing. 42 Third, these entities may not request or
require genetic testing for participants or beneficiaries. 43 ERISA ap-
plies these prohibitions to small group plans, while the PHSA is appli-
cable to individual insurance plans and non-federal governmental
plans.144 GINA outlines several enforcement mechanisms.145 The Act
also gives federal agency secretaries the power to impose monetary
penalties for not complying with this Act. 1 GINA also applies similar
prohibitions to issuers of Medigap policies. 1
47
First, group health plans, health insurance issuers, or issuers of
Medigap may not use or disclose genetic information to underwrite,
determine enrollment eligibility and rate premiums, or to create, re-
new, or replace a plan, contract, or coverage for health insurance or
health benefits. 48 These entities also may not request, require, or pur-
chase genetic information for such purposes. 149 They may not request,
require, or purchase genetic information prior to the enrollment of an
individual under their respective plan, coverage, or policy. 150 The Act
provides for an enforcement mechanism of the above provisions. 151
2. Prohibitions Against Employment Discrimination
GINA includes several provisions that prohibit employers as
well as employment agencies, labor organizations, and joint labor-
management committees'52 from discriminating against employees or
members because of their genetic information. 153 GINA prohibits a
wide range of discriminatory practices, including failing to hire an in-
dividual, discharging an employee, binding employees to discrimina-
tory terms of employment, failing or refusing to refer an individual for
employment, expelling a member, causing or attempting to cause an
142. Id.
143. Id.
144. Id.
145. Id.
146. Id.
147. Id. § 104.
148. Genetic Information Nondiscrimination Act, H.R. 493, 1 10th Cong. § 104 (2008).
149. Id.
150. Id.
151. Id. § 105.
152. Id. § 202 ("(2) EMPLOYEE; EMPLOYER; EMPLOYMENT AGENCY; LABOR
ORGANIZATION; AND MEMBER- The terms-- (A) 'employee,' 'employer,' 'employment
agency,' and 'labor organization' have the meanings given such terms in section 701 of the
Civil Rights Act of 1964 (42 U.S.C. 2000e); and (B) 'employee' and 'member,' as used with
respect to a labor organization, include an applicant for employment and an applicant for
membership in a labor organization, respectively.").
153. Id. § 202-205.
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employer to discriminate, or refusing admission to or employment in
an apprenticeship or other training program on the basis of genetic in-
formation. 154 These employment agencies, labor organizations, or joint
labor-management committees may not use genetic information to lim-
it, segregate, or classify individuals in any way that would deprive
them of employment opportunities or adversely encroach upon their
employment status.155 In addition, these entities may not request, re-
quire, or purchase an employee's genetic information, except to com-
ply with other statutory requirements or to monitor the biological ef-
fects of toxic substances in the workplace. 
56
Should an employer, employment agency, labor organization,
or joint labor-management committee possess the genetic information
of an individual, they must treat the information as a confidential med-
ical record and keep it in separate files. 157 These entities may only dis-
close such information "(1) to the employee or member upon request;
(2) to an occupational or other health researcher; (3) in response to a
court order; (4) to a government official investigating compliance with
the Genetic Nondiscrimination Act if the information is relevant to the
investigation; or (5) to comply with other statutory requirements."'' 58
Provisions for enforcement are included. 1
59
Under this Act, disparate impact 160 does not establish a cause
of action. 161 However, the Act establishes the Genetic Nondiscrimina-
tion Study Commission to review developments in genetics and to
make recommendations to Congress on whether to provide a disparate
impact cause of action. 162
154. Id.
155. Id.
156. Id. (may be requested or required to comply with the certification provisions of the
Family and Medical Leave Act of 1993 or such requirements under State family and medical
leave laws).
157. Id. § 206.
158. Id.
159. Id. § 207.
160. Caron v. Scott Paper Co., 834 F. Supp. 33, 36 (1993) ("The disparate impact mode
of analysis permits a plaintiff to recover for employment practices that are facially neutral in
their treatment of different groups but that in fact fall more harshly on one group than another
and cannot be justified by business necessity. Disparate impact claims assess the effects, rather
than the intent, of the practices, procedures, or tests neutral on their face.").
161. H.R. 493, 110th Cong. § 208 (2008).
162. Id.
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C. The Next Step. Regulating Group-Identity Genetics Research
Genetics has the ability to improve the public health, but it can
also affect our understanding of ethnicity and race. While members of
a race or ethnic group may have certain genetic similarities, these
groups are impossible to distinguish from each other on the genetic
level. 163 However, many scientists and clinicians continue to isolate
races and ethnic groups in their genetic studies for a number of rea-
sons. 164 First, a researcher may study a particular group if its members
exhibit high levels of a particular disease.' 65 Second, restricting re-
search to a particulate population can improve the results of certain
studies, especially those involving the identification of a gene.166 Fi-
nally, researchers have isolated racial and ethnic groups for non-
medical reasons, such as to study evolution.' 
67
Such studies may not only improve our understanding of genes,
race and ethnicity, but they may lead to stereotyping and affect rela-
tions between these groups. 168 This holds especially true if the results
of such studies are "tainted by racialization, historical attempts at eu-
genics, and the potential abuse of genetics targeting groups partially
defined by superficial genetic characteristics." 169 For such reasons, re-
search shows that African-Americans are more likely to oppose group-
identity based genetics research. 170 In addition, negative attitudes to-
wards group-identity based genetics research reduces the willingness
to undergo genetic testing, which are the precise results that legislation
like GINA was trying to prevent. 171
163. GENETIC RESEARCH: RACE, ETHNICITY & DISEASE: HANDBOOK FOR COMMUNITY
ORGANIZATIONS 13, available at http://www.societyandmedicine.columbia.edu/genetics-
cobook_3.shtml (last visited May 18, 2008).
164. Id.
165. Id. ("For instance, many studies investigating the genetic basis of diabetes are con-
ducted in Native-American and Alaska Native tribes where the incidence of the disease is
high. In such cases researchers may target the group in order to best address a pressing health
need. They may also target the group to increase the chance that a disease gene will be identi-
fied.")..
166. Id.
167. Id.
168. L. Allen Furr, Perceptions of Genetics Research As Harmful to Society: Differences
among Samples of African-Americans and European-Americans, 6(1) Genetic Testing 25, 25
(2002).
169. Id.
170. Id.
171. Id.
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While Congress and policymakers are directly addressing em-
ployment and insurance discrimination, 172 less drastic measures have
been undertaken to address the reinforcement of ethnic, racial, and
other group stereotypes. The use of racial, ethnic, and gender catego-
ries in genetics research, when combined with environmental, behav-
ioral, and psychological studies, may provide a better understanding of
common diseases and health disparities between such groups. In
addition, regulation may have the effect of stunting research, much of
which is funded and conducted by the National Institutes of Health
(NIH), the agency that envisioned and was the primary supporter of
GINA. 1
74
At this moment in time, the scientific community is taking
small steps to self-regulate. NIH has developed the Guidance for Ge-
netic Research. 175 NIH opposes genetic research that may reinforce
harmful stereotypes about particular populations or communities.
176
However, NIH guidance only regulates NIH-funded research. 177 In
addition, these guidelines do not delineate what types of group-identity
based research 178 would reinforce harmful stereotypes, most likely be-
cause the answer would differ on a case-by-case basis.1
79
Several scientific journals have issued their own genetics re-
search guidelines maintaining that researchers should carefully define
their descriptions of populations to avoid reinforcing stereotypes, and
reduce the use of group identities as proxies to describe certain popula-
172. See discussion supra Part V.B.
173. See Race, Ethnicity and Genetics Working Group, The Use of Racial, Ethnic, and
Ancestral Categories in Human Genetics Research, 17 American J. of Human Genetics 519,
519 (2005).
174. Genetic Discrimination, http://www.genome.gov/10002077 (last visited May 19,
2008) ("In the mid 1990s, the National Institutes of Health-Department of Energy (NIH-DOE)
Ethical, Legal and Social Implications (ELSI) Working Group and the National Action Plan
on Breast Cancer (NAPBC) cosponsored workshops on genetic discrimination in health insur-
ance and the workplace. The findings and recommendations of the workshops were published
in Science. They are the foundation for policy-making in the Executive branch, and for legisla-
tion at both the state and federal level.").
175. NIH COMMITTEE ON SCIENTIFIC CONDUCT AND ETHICS, NIH GUIDELINES FOR
RESEARCH, CHAPTER 24: GUIDANCE FOR GENETIC RESEARCH 12 (2007) (source on file with
author).
176. Id.
177. See Nat'l Human Genome Research Inst., Policy and Program Analysis Branch,
available at http://www.genome.gov/10001087 (last visited Jan. 2007).
178. Group-identity based research being defined as any research based on racial, ethnic,
and gender categories.
179. See NIH COMMITTEE ON SCIENTIFIC CONDUCT AND ETHICS, NIH GUIDELINES FOR
RESEARCH, CHAPTER 24: GUIDANCE FOR GENETIC RESEARCH 12 (2007) (source on file with
author).
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tions unless it is deemed necessary.' Some scientific journals have
asked researchers to justify their use of racial or ethnic groups in re-
search.181 However, scientific journals have not consistently enforced
these guidelines. 182 Nor do such journals provide any real regulatory
oversight that can stop or redirect research efforts.
The National Bioethics Advisory Commission recommends an
extension of human subject research protections to social groups, not
just individuals. 183 The commission proposes that investigators and
ethics review boards "a) work directly with community representatives
to develop study methods that minimize potential group harms, b) dis-
cuss group implications as part of the informed consent process, and c)
consider group harms in reporting research results."' 84 Again, at this
stage, these recommendations are only recommendations.
Federal and state legislators have infrequently stepped in to re-
gulate the actual content of biomedical research, but it is not unheard
of in the genomic era. 85 These instances have been limited to ex-
tremely controversial types of genetic research, like cloning and stem
cell research. It remains to be seen to what extent group-identity based
research will reinforce stereotypes and how, if at all, such research
could be regulated without destroying the rewards it reaps. As our un-
derstanding of the human genome improves, as well as its impact on
medical research, these issues must be addressed.
VI. CONCLUSION
Genetic discrimination is a serious issue, not only to individu-
als with genetic predispositions to disease, but also to their families,
their communities, the scientific community, and the biotechnology
and pharmaceutical industries. 186 Because of the negative implications
of genetic discrimination resulting from a lack of adequate legal pro-
tections, Congress passed the Genetic Information Nondiscrimination
180. See Race, Ethnicity and Genetics Working Group, supra note 178, at 527.
181. Id.
182. Id.
183. Richard R. Sharp and Morris W. Foster, Community involvement in the ethical re-
view of genetic research: lessons from American Indian and Alaska Native populations,
110(2) Environmental Health Perspect 145, 145 (2002).
184. Id.
185. See generally Nat'l Human Genome Research Institute, Welcome to the NHGRI
Policy and Legislation Database, available at http://www.genome.gov/PolicyEthics/
LegDatabase/pubsearch.cfm (database contains genetics legislation from all fifty states, the
federal government, as well as other sources).
186. See discussion supra Part III.
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Act.' 87 Only with such protections will people be willing to undergo
genetic testing to inform themselves about their genetic predispositions
to certain disease so they may take a more proactive role in their health
care. 188 While the Genetic Information Nondiscrimination Act is a ma-
jor success for individuals, families, and the public health community
alike, additional steps should be taken to assure that genetic research
does not lead to population-wide racial, ethnic or sexual discrimina-
tion. 189 This would bring genetic nondiscrimination efforts full circle
and protect individuals from misconceptions with eugenic roots. 190
187. See discussion supra Part IV; see discussion supra Part V.A; see discussion supra
Part V.B.
188. See discussion supra Part III.
189. See discussion supra Part V.C.
190. See discussion supra Part II1.C.
